Internet of Things
NeuroSigma gets green light from FDA for ADHD wearable
The company plans to enrol 375 subjects in two clinical trials in the US and the UK by the end of 2024.
The company plans to enrol 375 subjects in two clinical trials in the US and the UK by the end of 2024.